Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700021549

Trial Profile

Clinical Trials Insight: 700021549

Phase of Trial: Phase II

Latest Information Update: 21 May 2009

At a glance

  • Drugs Vadimezan (Primary) ; Carboplatin; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Antisoma
  • Most Recent Events

    • 21 May 2009 Results have been published in the journal Lung Cancer, according to an Antisoma media release.
    • 01 Jun 2008 Results presented at ASCO 2008.
    • 13 Sep 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top